Yoko Aoki

9.8k citations
170 papers · 4.8k indexed · 1 hit paper · h-index 36

Yoko Aoki

165 papers receiving 4.7k citations

Hit Papers

A genome-wide association study identifies RNF213 as the ...5142010202620152020100200300400500

Peers

Yoko Aoki
Comparison fields: 5 of 114
  • Clinical Biochemistry 408
  • Rheumatology 762
  • Molecular Biology 2.9k
  • Immunology 891
  • Neurology 546
Replace Vorasuk Shotelersuk with:
Vorasuk Shotelersuk Thailand
Toya Ohashi Japan
Luisa Bonafé Switzerland
Maja Di Rocco Italy
Mirella Filocamo Italy
Sara Mole United Kingdom
Joel Charrow United States
Brendan Lee United States
Yair Anikster Israel
Robert Steinfeld Germany
Yoko Aoki relative to Vorasuk Shotelersuk Thailand Vorasuk Shotelersuk's profile →
Citations per field
00.5×4.9×
Vorasuk Shotelersuk · 1×
Citations per year

Countries citing papers authored by Yoko Aoki

Since Specialization
Citations

This map shows the geographic impact of Yoko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Aoki more than expected).

Fields of papers citing papers by Yoko Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Aoki. The network helps show where Yoko Aoki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoko Aoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoko Aoki Line = papers co-authored together Yoko Aoki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20241
3 20231
4 20231
5 20232
6 202212
7 20223
8 20217
9 202038
10 20182
11 201731
12 201711
13 201428
14 201035
15 20097
16 200429
17 200213
18 199919
19 199849
20
19865

About Yoko Aoki

Yoko Aoki is a scholar working on Clinical Biochemistry, Immunology and Molecular Biology, having authored 170 papers that have together received 4.8k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (47 papers), Galectins and Cancer Biology (30 papers), Metabolism and Genetic Disorders (16 papers), Biotin and Related Studies (13 papers), Peptidase Inhibition and Analysis (13 papers), RNA modifications and cancer (12 papers), RNA regulation and disease (10 papers) and Mitochondrial Function and Pathology (8 papers). The work is most often cited by research in Clinical Biochemistry (408 citations), Rheumatology (762 citations) and Molecular Biology (2.9k citations). Yoko Aoki has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Yoichi Matsubara, Tetsuya Niihori, Shigeo Kure, Yoichi Suzuki, Shinichi Inoue, Yoko Narumi, Kenji Kurosawa, Hirofumi Ohashi, Hiroshi Kawame and Yukichi Tanaka. Their work appears in journals such as Brain and Development, Molecular Genetics and Metabolism, Human Mutation, Human Molecular Genetics and Journal of Pediatric Hematology/Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026